Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Masimo logo — Masimo innovations empower clinicians to transform patient c...

Masimo

Masimo innovations empower clinicians to transform patient care.

Founded 1989 United States Irvine, United States 3534 employees IPO Total: $755.00M Biotechnology, Health Care +2

General Information

Company Name Masimo
Founded Year 1989
Location United States Irvine, United States
Employees 3534
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage IPO
Social

BounceWatch is an independent company data service, not affiliated with Masimo. To contact Masimo, visit masimo.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Masimo compare?

A PDF of Masimo and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Masimo soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Masimo

Masimo (NASDAQ: MASI), founded in 1989, is a pioneering force in the Biotechnology, Health Care, Manufacturing, and Medical Devices industries, with a focus on developing innovative noninvasive patient monitoring technologies. Based in the United States, the company is renowned for its clinically-proven products that empower healthcare providers with critical data to optimize clinical decisions.

The company's slogan, "Improving life. Improving patient outcomes and reducing the cost of care," encapsulates its commitment to enhancing patient care and safety. Over its decades-long journey, Masimo has consistently tackled 'unsolvable' problems, building a portfolio that includes advanced medical devices and sensors.

Recently, Masimo secured a significant $750.00M Post-IPO Equity investment on 15 August 2022, led by Politan Capital Management. This investment underscores strong market confidence and positions Masimo for continued innovation and growth in the competitive medical technology landscape.

Business keywords: Medical Technology, Patient Monitoring, Noninvasive Monitoring, Healthcare Innovation, Clinical Decision Making, Patient Safety, Sensors, Innovative Solutions, Healthcare Outcomes, Cost Reduction, Medical Innovations, Global Impact

Services & Products

Patient Monitoring Systems
Emergency Medical Services Solutions
Healthcare Automation
Remote Monitoring and Notification
Medical Device Integration
Clinical Analytics

Target Customers

Hospitals Healthcare Professionals Emergency Medical Services ICU and NICU Facilities Home Care Providers Contract Research Organizations Government and Military Healthcare Units

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity $750.00M -
01 Aug 2022
Post-IPO Equity Undisclosed 1
Robeco
Robeco
01 Aug 2017
Grant $5.00M 1
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
01 Nov 2016
IPO Undisclosed -
01 Aug 2007
Round Undisclosed 1
Signatures Capital
Signatures Capital
01 Jul 2000

Latest News

View All
Apple Watch getting redesigned blood oxygen feature following legal dispute — Cnbc
Apple Watch getting redesigned blood oxygen feature following legal dispute
Cnbc Aug 14, 2025
Masimo activist director Koffey demands ‘basic’ information on company’s proposed spinoff — Cnbc
Masimo activist director Koffey demands ‘basic’ information on company’s proposed spinoff
Cnbc May 10, 2024
Masimo seeks to stave off proxy fight with Politan, makes settlement offer — Cnbc
Masimo seeks to stave off proxy fight with Politan, makes settlement offer
Cnbc May 09, 2024
Activist investor plans second fight at Masimo, sending shares up 5% — Cnbc
Activist investor plans second fight at Masimo, sending shares up 5%
Cnbc Mar 25, 2024

Masimo Alternatives & Competitors

View All Alternatives
Masimo vs
GlucoSet
GlucoSet Norway

Intensive care monitoring

16 employees
Biotechnology, Health Care
Compare Masimo vs GlucoSet
Masimo vs
SafeGuard Surgical
SafeGuard Surgical

A Life-Saving Biodegradable Startup

Seed
6 employees
Biotechnology, Health Care
Compare Masimo vs SafeGuard Surgical
Masimo vs
Abtrace
Abtrace United Kingdom

Machine learning and clinical innovation to reshape the delivery of primary care

Non Equity Assistance
39 employees
AI, Health Care
Compare Masimo vs Abtrace
Also compare with: Masimo vs Able Innovations Able Innovations View all alternatives

FAQ About Masimo

Masimo innovations empower clinicians to transform patient care.
Masimo was founded in 1989.
Masimo is headquartered in Irvine, United States.
Masimo operates in Biotechnology, Health Care, Manufacturing and Medical Devices. Its work centres on Medical Technology, Patient Monitoring, Noninvasive Monitoring and Healthcare Innovation. Its customers include Hospitals, Healthcare Professionals and Emergency Medical Services.
Masimo has approximately 3534 employees.
Masimo has completed 5 funding rounds, raising a total of $755.00M. The latest funding stage is IPO.
Masimo offers: Patient Monitoring Systems, Emergency Medical Services Solutions, Healthcare Automation, Remote Monitoring and Notification, Medical Device Integration, Clinical Analytics.
Top alternatives and competitors to Masimo include GlucoSet, SafeGuard Surgical, Abtrace, Etiometry Inc., Medsix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Masimo and GlucoSet are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Masimo, https://bouncewatch.com/company/masimo, updated 23 October 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes